Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Colitis, Ulcerative 4Inflammatory Bowel Diseases 3Crohn Disease 3Arthritis, Rheumatoid 3Graft vs Host Disease 2Cachexia 2Anorexia 2Recurrence 1Rare Diseases 1Psoriasis 1Pancreatic Neoplasms 1Lymphoma 1Lung Neoplasms 1Kidney Transplantation 1Inflammation 1Hypertension 1Gastrointestinal Diseases 1Fatigue 1Depressive Disorder, Treatment-Resistant 1Depressive Disorder, Major 1Depression 1Carcinoma, Non-Small-Cell Lung 1Bronchiolitis Obliterans Syndrome 1Bipolar Disorder 1Arthritis, Psoriatic 1Anemia 1

Interventions

Exercise 5Vitamin D 2Tea 2Sufentanil 2Spironolactone 2Probiotics 2Oxycodone 2Omeprazole 2Morphine 2Metformin 2Etanercept 2Colchicine 2Ascorbic Acid 2ziprasidone 1soybean oil, phospholipid emulsion 1salicylsalicylic acid 1ginger extract 1falcarinol 1falcarindiol 1epigallocatechin gallate 1Zolpidem 1Warfarin 1Vecuronium Bromide 1Vancomycin 1Tumor Necrosis Factors 1Tranexamic Acid 1Tobramycin 1Sulindac 1Sodium Salicylate 1Sodium Chloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Inflammation × Infliximab × Clear all
NCT02743390 2017-11-09

Effects of the TNF-alpha Inhibiton on Hemodynamic Parameters in Resistant Hypertension

University of Campinas, Brazil

Phase 4 Completed
10 enrolled

Hypertension, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡